LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism

Development

Volumn 132, Issue 5, 2005, Pages 885-896

  Cartwright, Peter ^a   McLean, Cameron ^a   Sheppard, Allan ^a   Rivett, Duane ^a   Jones, Karen ^a   Dalton, Stephen ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

ES cells; Myc; Pluripotency; Self renewal

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; LEUKEMIA INHIBITORY FACTOR; MYC PROTEIN; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL RENEWAL; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENZYME REPRESSION; GENE TARGETING; IN VIVO STUDY; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; BLOTTING, NORTHERN; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; DOWN-REGULATION; EMBRYO; FLOW CYTOMETRY; GLYCOGEN SYNTHASE KINASE 3; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PHOSPHORYLATION; PLASMIDS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; STEM CELLS; TIME FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

ANIMALIA; MURINAE;

EID: 16844364151     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.01670     Document Type: Article

References (54)

1. Boeuf, H., Merienne, K., Jacquot, S., Duval, D., Zeniou, M., Hauss, C., Reinhardt, B., Huss-Garcia, Y., Dierich, A., Frank, D. A. et al. (2001). The ribosomal S6 kinases, cAMP-responsive element-binding, and STAT3 proteins are regulated by different leukemia inhibitory factor signaling pathways in mouse, embryonic stem cells. J. Biol. Chem. 276, 46204-46211.
2. Boulton, T. G., Stahl, N. and Yancopoulos, G. D. (1994). Ciliary neurotropic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induce tyrosine phosphorylation of a common set of proteins overlapping these induced by other cytokines and growth factors. J. Biol. Chem. 269, 11648-11655.
3. Bowman, T., Broome, M. A., Sinibaldi, D., Wharton, W., Pledger, W. J., Sedivy, J. M., Irby, R., Yeatman, T., Courtenage, S. A. and Jove, R. (2001). Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc. Natl. Acad. Sci. USA. 98, 7319-7324.
4. Calaveri, F. and Scholer, H. R. (2003). Nanog: new recruit to the embryonic stem cell orchestra. Cell 113, 551-552.
5. Canelles, M., Delgado, M. D., Hyland, K. M., Lerga, A., Richard, C., Dang, C. V. and Leon, J. (1997). Max and inhibitory c-myc mutants induce erythroid differentiation and resistance to apoptosis in human myeloid leukemia cells. Oncogene 14, 1315-1127.
6. Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S. and Smith, A. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655.
7. Chang, D. W., Claassen, G. F., Hann, S. R. and Cole, M. D. (2000). The c-Myc transactivation is a direct modulator of apoptotic versus proliferative signals. Mol. Cell. Biol. 20, 4309-4319.
8. Darnell, J. E., Jr (1997). STATs and gene regulation. Science 277, 1630-1635.
9. Davis, A. C., Wims, M., Spotts, G. D., Hann, S. R. and Bradley, A. (1993). A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 7, 671-682.
10. Doetschman, T. C., Eistetter, H., Katz, M., Schmidt, W. and Kemler, R. (1985). The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Esp. Morphol. 87, 27-45.
11. Downs, K. M., Martin, G. R. and Bishop, J. M. (1989). Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. Genes Dev. 3, 860-869.
12. Eilers, M., Picard, D., Yamamoto, K. R. and Bishop, J. M. (1989). Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation. Nature 340, 66-68.
13. Ellwood-Yen, K., Graeber, T. G., Wongyipat, J., Iruela-Arispe, M. L., Zhang, J., Matusik, R., Thomas, G. V. and Sawyers, C. L. (2003). Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4, 223-238.
14. Fernandez, P. C., Frank, S. R., Wang, L., Schroeder, M., Liu, S., Greene, J., Cocito, A. and Amati, B. (2003). Genomic tragets of the human c-myc protein. Genes Dev. 17, 1115-1129.
15. Frye, M., Gardner, C., Li, E. R., Arnold, I. and Watt, E. M. (2003). Evidence that c-myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment. Development 130, 2793-2808.
16. Gregory, M. A., Qi, Y. and Hann, S. R. (2003). Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J. Biol. Chem. 278, 51606-51612.
17. Hadjantonakis, A. K., Gertsenstein, M., Ikawa, M., Okabe, M. and Nagy, A. (1998). Generating green fluorescent mice by germline transmission of green fluorescent ES cells. Mech. Dev. 76, 79-90.
18. He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B. and Kinzler, K. W. (1998). Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512.
19. Hogan, B., Beddington, R., Constantini, E. and Lacy, E. (1994). Manipulating the Mouse Embryo. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
20. Humphrey, R. K., Beattie, G. M., Lopez, A. D., Bucay, N., King, C. C., Firpo, M. T., Rose-John, S. and Hayek, A. (2004). Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem Cells 22, 522-530.
21. Kenney, A. M., Widlund, H. R. and Rowitch, D. H. (2004). Hedgehog and PI-3 kinase signaling converge on Nmyc1 to promote cell cycle progression in cerebellar neuronal precursors. Development 131, 217-228.
22. Kiuchi, N., Nakajima, K., Ichiba, M., Fukada, T., Narimatsu, M., Mizuno, K., Hibi, M. and Hirano, T. (1999). STAT3 is required for the gp130-mediated full activation of the c-myc gene. J. Exp. Med. 189, 63-73.
23. Knoepfler, P. S., Cheng, P. F. and Eisenman, R. N. (2002). N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev. 16, 2699-2712.
24. MacLean-Hunter, S., Makela, T. P., Grzeschiczek, A., Alitalo, K. and Moroy, T. (1994). Expression of a RLF/L-MYC ntinigene inhibits differentiation of embryonic stem cells and embryoid body formation. Oncogene 9, 3509-3517.
25. Malynn, B. A., de Alboran, I. M., O'Hagan, R. C., Bronson, R., Davidson, L., DePinho, R. A. and Alt, E. W. (2000). N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev. 14, 1390-1399.
26. Matsuda, T., Nakamura, T., Nakao, K., Arai, T., Katsuki, M., Heike, T. and Yokota, T. (1999). STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 18, 4261-4269.
27. Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., Maruyama, M., Maeda, M. and Yamanaka, S. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642.
28. Niwa, H., Burdon, T., Chambers, I. and Smith, A. (1998). Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12, 2048-2060.
29. Niwa, H., Miyazaki, J.-I. and Smith, A. G. (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24 372-376.
30. Oka, M., Tagoku, K., Russell, T. L., Nakano, Y., Hamazaki, T., Meyer, E. M., Yokota, T. and Terada, N. (2002). CD9 is associated with leukemia inhibitory factor-mediated maintenance of embryonic stem cells. Mol. Biol. Cell 13, 1274-1281.
31. Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T. and Nishimune, Y. (1997). 'Green mice' as a source of ubiquitous green cells. FEBS Letts. 407, 313-319.
32. Orian, A., vam Stensel, B., Delrow, J., Bussemaker, H. J., Li, L., Sawado, T., Williams, E., Loo, L. W., Cowley, S. M., Yost, C., Pierce, S., Edgar, B. A., Parkhurst, S. M. and Eisenman, R. N. (2003). Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev. 17, 1101-1114.
33. Oster, S. K., Ho, C. S., Soucie, E. L. and Penn, L. Z. (2002). The myc oncogene: marvelously complex. Adv. Cancer Res. 84, 81-154.
34. Paling, N. R. D., Wheadon, H., Bone, H. K. and Welham, M. J. (2005). Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase dependent signalling. J. Biol. Chem. 279, 48063-48070.
35. Patel, J. H., Loboda, A. P., Showe, M. K., Showe, L. C. and McMahon, S. B. (2004). Analysis of genomic targets reveal complex functions of MYC. Nat. Rev. Cancer 4, 562-568.
36. Pelengaris, S., Littlewood, T., Khan, M., Elia, G. and Evan, G. (1999). Reversible activation of c-myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol. Cell 3, 565-577.
37. Pratt, T., Sharp, L., Nichols, J., Price, D. J. and Mason, J. O. (2000). Embryonic stem cells and transgenic mice ubiquitously expressing a tau-tagged green fluorescent protein. Dev. Biol. 228, 19-28.
38. Qi, X., Li, T.-G., Hao, J., Hu, J., Wang, J., Simmons, H., Miura, S., Mishina, Y. and Zhao, G.-Q. (2004). BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways. Proc. Natl. Acad. Sci. USA 101, 6027-6032.
39. Reya, T., Duncan, A. W., Allies, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R. and Weissman, I. L. (2003). A role for Wnt signaling in self-renewal of haematopoietic stem cells. Nature 423, 409-414.
40. Sato, N., Meijer, L., Skaltsounis, L., Greengard, P. and Brivanlou, A. H. (2004). Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10, 55-63.
41. Satoh, Y., Matsumura, I., Tanaka, H., Ezoe, S., Sugahara, H., Mizuki, M., Shibayama, H., Ishiko, J., Nakajima, K. and Kanakura, Y. (2004). Roles for c-Myc in self-renewal of hematopoietic stem cells. J. Biol. Chem. 279, 24986-24993.
42. Schreiner, S., Birke, M., Garcia-Cuellar, M.-P., Zilles, O., Greil, J. and Slany, R. K. (2001). MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation. Cancer Rev. 61, 6480-6486.
43. Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K. and Nevins, J. R. (2000). Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14, 2501-2514.
44. Selvakumaran, M., Lieberman, D. and Hoffman, B. (1996). The proto-oncogene c-myc blocks myeloid differentiation independently of its target gene ornithine decarboxylase. Blood 4, 1248-1256.
45. Shen-Li, H., O'Hagan, R. C., Hou, H., Jr, Horner, J. W., II, Lee, H.-W. and DePinho, R. A. (2000). Essential role for Max in early embryonic growth and development. Genes Dev. 14, 17-22.
46. Shirogane, T., Fukada, T., Muller, J. M. M., Sima, D. T., Hibi, M. and Hirano, T. (1999). Synergistic roles for Pim-1 and c-myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity 11, 709-719.
47. Stanton, B. R., Perkins, A. S., Tessarollo, L., Sassoon, D. A. and Parada, L. F. (1992). Loss of N-myc function results in embryonic lethality and failure of the epidermal component of the embryo to develop. Genes Dev. 6, 2235-2247.
48. Stead, E., White, J., Faast, R., Conn, S., Goldstone, S., Rathjen, J., Dhingra, U., Rathjen, P., Walker, D. and Dalton, S. (2002). Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene 21, 8320-8333.
49. Takahashi-Tezuka, M., Yoshida, Y., Fukada, T., Ohtani, T., Yamanaka, Y., Nishida, K., Nakajima, K., Hibi, M. and Hirano, T. (1998). Gab1 acts as an adaptor molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase. Mol. Cell. Biol. 18, 4109-4117.
50. Waikel, R. L., Kawachi, Y., Waikel, P. A., Wang, X. J. and Roop, D. R. (2001). Deregulated expression of c-myc depletes epidermal stem cells. Nat. Genet. 28, 165-168.
51. Wang, J., Xie, L. Y., Allan, S., Beach, D. and Hannon, G. J. (1998). Myc activates telomerase. Genes Dev. 12, 1769-1774.
52. Welcker, M., Orian, A., Jin, J., Grim, J. A., Harper, J. W., Eisenman, R. N. and Clurman, B. E. (2004). The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc. Natl. Acad. Sci. USA 101, 9085-9090.
53. Yeh, E., Cunningham, M., Arnold, H., Chasse, D., Monteith, T., Ivaldi, G., Hahn, W. C., Stukenberg, P. T., Shenolikar, S., Uchida, T. et al. (2004). A signalling pathway controlling c-myc degradation that impacts oncogenic transformation of human cells. Nat. Cell Biol. 6, 308-318.
54. Ying, Q.-L., Nichols, J., Chambers, I. and Smith, A. (2003). BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281-292.